Macquarie Group
SRGA

Macquarie Group’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Macquarie Group’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-215
Closed -$24K – 2179
2018
Q4 		$24K Sell
215
-1,411
-87% -$184K ﹤0.01% 1755
2018
Q3 		$220K Sell
1,626
-1,187
-42% -$164K ﹤0.01% 1460
2018
Q2 		$388K Sell
2,813
-22
-0.8% -$3.03K ﹤0.01% 1446
2018
Q1 		$391K Sell
2,835
-804
-22% -$109K ﹤0.01% 1467
2017
Q4 		$448K Buy
3,639
+1,589
+78% +$218K ﹤0.01% 1480
2017
Q3 		$280K Buy
+2,050
New +$309K ﹤0.01% 1639

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HC
Hillman Company Pittsburgh, Pennsylvania $257M AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group's SRGA Position: Q1 2019 in Review

Macquarie Group sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2019, closing a stake of 215 shares — an estimated $24K sold.

Macquarie Group first reported a position in SRGA in Q3 2017 and held it in 6 quarters. The position peaked at $448K in Q4 2017. 113 funds tracked by Wall St. Rank hold SRGA as of Q1 2019.

  • Macquarie Group reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Macquarie Group sold 215 Surgalign Holdings, Inc. Common Stock shares in Q1 2019, an estimated $24K.
  • Macquarie Group first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
  • Macquarie Group's Surgalign Holdings, Inc. Common Stock position peaked at $448K in Q4 2017.
  • 113 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.